Johnson & Johnson vs. Kazia Therapeutics Limited American Depositary Shares
JNJ
Johnson & Johnson
$268.04 +0.85%
VS KZIAKazia Therapeutics Limited American Depositary Shares
$13.58 -19.64%
Johnson & Johnson and Kazia Therapeutics Limited American Depositary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | KZIA | |
|---|---|---|
| Market Cap | $645.95 billion | $155.18 million |
| Revenue (TTM) | $97.93 billion | — |
| Net Income (TTM) | $21.04 billion | — |
JNJ leads on 1 of 1 size & scale factors.
Valuation
| JNJ | KZIA | |
|---|---|---|
| P/E Ratio | 31.10 | — |
| Price / Book | 7.60 | — |
| Price / Sales | 6.60 | — |
JNJ and KZIA split the valuation factors evenly.
Profitability
| JNJ | KZIA | |
|---|---|---|
| Net Margin | 21.48% | — |
| Return on Equity | 24.76% | — |
JNJ and KZIA split the profitability factors evenly.
Dividend
| JNJ | KZIA | |
|---|---|---|
| Dividend Yield | 2.00% | — |
| Payout Ratio | 62.18 | — |
JNJ and KZIA split the dividend factors evenly.
Risk & Sentiment
| JNJ | KZIA | |
|---|---|---|
| Short Interest | 0.67% | 0.04% |
KZIA leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, KZIA overview, KZIA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.